Effectiveness of single dose augmentin in elective major gynecological surgery as a prophylaxis. (Record no. 510)

MARC details
000 -LEADER
fixed length control field 02799 a2200229 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220906184544.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 190207b ||||| |||| 00| 0 eng d
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number THS-00055
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Thapa, Meena.
9 (RLIN) 1642
245 ## - TITLE STATEMENT
Title Effectiveness of single dose augmentin in elective major gynecological surgery as a prophylaxis.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Date of publication, distribution, etc. c2001.
300 ## - PHYSICAL DESCRIPTION
Extent vii, 68p.
500 ## - GENERAL NOTE
General note Thesis Report.
520 ## - SUMMARY, ETC.
Summary, etc. ABSTRACT: Objective- To study effectiveness of single dose Augmention in preventing post operative infective morbidity in elective major gynecological study. Mehods- A prospective and comparative study carried out in Maternity Hospital, Thapathali, where annually around 600 elective major gynecological surgery are done. During study period 149 elective gynecological were performed in the hospital. 96 women, who came for effective major gynecological, surgery, were enrolled in the study. Among which, 48 cases in group I were given 1.2 gm of Inj. Augmentin intra operatively, rest of the patient (48 cases) in group ii, were given 200 mg of Inj. Ciprofloxacin twice a day and Metronidazole 500 mg thrice a day for 24-48 hrs. post operatively. Then, they were given oral Ciprofloxacin 500 mg twice a day, & Metronidazole 400 mg thrice a day 5 more days. Febrile illness, urinary bacterial growth in post operatively catheterized patients, signs of wound infection and length of post operative hospital stay, were compared between groups. Results- Febrile morbidity were seen in one case each of both groups (2.08%). Both of them were seen in cases of abdominal surgery. The case of fever belonged to Augmentin group was associated with more blood loss (> 500 ml) and blood transfusion, where as other case did not have contributing factor. 5 cases (16.6%) out of 30 cases belonged to Augmentin group and 4 cases (13.8%) out of 29 cases belonged to Ciprofloxacin and Metronidazole group had urinary bacterial growth in their urine (p> 0.05). All the cases of urinary bacterial growth were seen only in vaginal surgical cases. 4 cases (10.8%) in Augmentin group and 5 cases (12.4%) in Ciprofloxacin group had induration in their abdominal and perineal wound. Significant difference in post operative hospital stay was not found between groups (p > 0.05). Infective events in patients were found associated with advancing age and more blood loss. Conclusion- Single dose (1.2 gm) Augmentin is as effective as multiple dose of ciprofloxacin in preventing infective morbidity in patients undergoing elective major gynecological surgery.
546 ## - LANGUAGE NOTE
Language note Eng.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Single dose augmentin.
9 (RLIN) 1729
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gynecological surgery.
9 (RLIN) 1730
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prophylaxis.
9 (RLIN) 1731
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://nhrc.gov.np/contact/">http://nhrc.gov.np/contact/</a>
Link text Visit NHRC Library
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme National Library of Medicine
Koha item type Thesis Report
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
    National Library of Medicine     Nepal Health Research Council Nepal Health Research Council Reference 07/12/2012   THS-00055/THA/2001 THS-00055 07/12/2012 07/12/2012 Thesis Report

Nepal Health Research Council © 2024.

Ramshah Path, Kathmandu, Nepal, P.O.Box 7626

Web: https://nhrc.gov.np/ | Email : nhrc@nhrc.gov.np | Phone : 977-1-4254220

Maintained by Chandra Bhushan Yadav, Library & Information Officer, NHRC